Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy
Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy have?
Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy has 30 citations in the OpenAlex counts ScholarIQ stores.
When was Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy published?
Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy has 2017 year in the ScholarIQ index.
What is the open-access status of Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy?
Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy has bronze oa status in the ScholarIQ index.
What is the DOI of Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy?
The DOI for Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy is on the source record.
What is the PMID of Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy?
The PMID for Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy is on the source record.
What is the OpenAlex record for Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy?
The OpenAlex for Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy is on the source record.